RYTM
RHYTHM PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$88.23
+2.39%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 33.92x
- P/S forward
- 12.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 27.96x
- Price / sales
- 25.32x
- Price / cash flow
- -40.63x
Enterprise value
- Enterprise value
- $5.9B
- EV / sales
- 24.43x
- EV / EBITDA
- -31.73x
- EV / EBIT
- -29.22x
- Market cap
- $6.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026